23Serious

CRISPR

Ask VT AI

View News Summary

Tether expands into the U.S. market with the launch of USAT, a new stablecoin compliant with the GENIUS Act, and appoints Bo Hines as CEO of its U.S. operations.
Intense Championship clash as Charlton and Millwall battle for points, with both teams struggling offensively.
High school football scores reported across multiple states, highlighting key plays and competitive spirit as the season progresses.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Latest News

CRISPR, Biotechnology

CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers

100% left coverage1 source

CRISPR, Biotechnology

CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers

100% left coverage1 source

CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers

CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers

CRISPR, Biotechnology

Japanese Court Upholds UC CRISPR Patent in Global Legal Battle

100% left coverage1 source

CRISPR, Biotechnology

Japanese Court Upholds UC CRISPR Patent in Global Legal Battle

100% left coverage1 source

Japanese Court Upholds UC CRISPR Patent in Global Legal Battle

Japanese Court Upholds UC CRISPR Patent in Global Legal Battle

CRISPR, Biotechnology

CRISPR Center Launches with $20M to Develop Personalized Therapies

100% left coverage2 sources

CRISPR, Biotechnology

CRISPR Center Launches with $20M to Develop Personalized Therapies

100% left coverage2 sources

CRISPR Center Launches with $20M to Develop Personalized Therapies

CRISPR Center Launches with $20M to Develop Personalized Therapies

CRISPR, Biotechnology

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

100% left coverage1 source

CRISPR, Biotechnology

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

100% left coverage1 source

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

CRISPR, Biotechnology

CRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results

100% left coverage1 source

CRISPR, Biotechnology

CRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results

100% left coverage1 source

CRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results

CRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results

CRISPR, Biotechnology

GAMMA Investing LLC Dramatically Increases Stakes in CRISPR Therapeutics, Structure Therapeutics, REGENXBIO

100% left coverage1 source

CRISPR, Biotechnology

GAMMA Investing LLC Dramatically Increases Stakes in CRISPR Therapeutics, Structure Therapeutics, REGENXBIO

100% left coverage1 source

GAMMA Investing LLC Dramatically Increases Stakes in CRISPR Therapeutics, Structure Therapeutics, REGENXBIO

GAMMA Investing LLC Dramatically Increases Stakes in CRISPR Therapeutics, Structure Therapeutics, REGENXBIO

CRISPR, Business Leaders

Scientists Develop Large-Scale Precise Gene-Editing Tools Across Plants, Humans

100% center coverage1 source

CRISPR, Business Leaders

Scientists Develop Large-Scale Precise Gene-Editing Tools Across Plants, Humans

100% center coverage1 source

Scientists Develop Large-Scale Precise Gene-Editing Tools Across Plants, Humans

Scientists Develop Large-Scale Precise Gene-Editing Tools Across Plants, Humans

Ask VT AI

View News Summary

Tether expands into the U.S. market with the launch of USAT, a new stablecoin compliant with the GENIUS Act, and appoints Bo Hines as CEO of its U.S. operations.
Intense Championship clash as Charlton and Millwall battle for points, with both teams struggling offensively.
High school football scores reported across multiple states, highlighting key plays and competitive spirit as the season progresses.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Most Reported By
News from CRISPR